[Cabergoline].
Mönig
H
H
I. Medizinische Klinik, Christian-Albrechts-Universität, Kiel.
Krack
P
P
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D004873:Ergolines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D005260:Female; D006801:Humans; D011247:Pregnancy; D011388:Prolactin / Q000037:antagonists & inhibitors
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D004873:Ergolines; D011388:Prolactin; D000077465:Cabergoline
Cabergolin.